pocketful logo light
pocketful logo light
Vivimed Labs Ltd logo

Vivimed Labs Ltd

NSE: VIVIMEDLAB BSE: 532660

6.26

(3.84%)

Sat, 30 May 2026, 03:28 pm

Vivimed Labs Share Price Live Chart

1 Day

(3.84%)

No Result Found

Summary

  • Market Cap

    54.81

  • Net Profit

    -31.96

  • P/B

    0

  • Sector P/E

    34.30

  • P/E

    0

  • EV/EBITDA

    0

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    14.04

  • RONW (Industry)

    13.17

  • ROE

    0

  • ROCE

    0

  • Debt/Equity

    0

  • EPS (TTM)

    0

  • Dividend Yield

    0

  • Book Value

    -10.37

  • Interest Cover

    -9.69

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters7.577.777.777.7720.94
FII1.641.641.641.641.64
DII00000
Public90.6790.4890.4890.4877.30
Government0.120.120.120.120.12

Read More

Technical Analysis

RSI

51.82

MACD

-0.08

50 DMA

6.62

200 DMA

8.97

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic12.589.638.206.685.253.730.78
Fibonacci9.638.507.806.685.554.853.73
Camarilla7.597.327.056.686.516.245.97

Pivots Level: Classic

R3

+5.90

12.58

R2

+2.95

9.63

R1

+1.53

8.20

6.68
6.68
Pivot Point
LTP: 6.72

S1

-1.42

5.25

S2

-2.95

3.73

S3

-5.90

0.78

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    6.55

  • 20-EMA

    6.61

  • 30-EMA

    6.67

  • 50-EMA

    6.88

  • 100-EMA

    7.59

  • 200-EMA

    8.90

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
30 May 2026board-meetingsAccounts, Quarterly Results
28 May 2026board-meetingsAccounts, Quarterly Results
13 Mar 2026board-meetingsQuarterly Results
13 Feb 2026board-meetingsQuarterly Results
17 Nov 2025egm
13 Nov 2025board-meetingsQuarterly Results
06 Sept 2025agm
11 Dec 2024agm
27 Nov 2024agmAnnual General Meeting28 Dec 2024
05 Jul 2024egm

Read More

Peer Comparison

Vivimed Labs Ltd logo

Vivimed Labs Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Vivimed Labs Ltd About

Vivimed Labs is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1988

Headquarters

CEO

V Manohar Rao

Employees

Contact

Website icon

Website

http://www.vivimedlabs.com

Email icon

Email

yugandhar.kopparthi@vivimedlabs.com

Phone icon

Phone

91-8482-232045

Location icon

Location

Plot No 78-A, Kolhar Industrial Area, Bidar, Karnataka, 585403

Read More

Vivimed Labs Ltd Company History

YearHistory
2012
  • Vivimed launch Nisarg Soapnut at in-cosmetics, Barcelona
  • Mr. K. Yugandhar has been appointed as Company Secretary of the company
2013
  • Vivimed acquires a US FDA approved formulation manufacturing facility
  • Vivimed are Exhibiting at HPCi - Mumbai
2014
  • Vivimed receives the PIC/S GMP approval for one of its pharmaceuticals manufacturing facilities in Hyderabad
  • Vivimed Labs - Grant of Options under Vivimed Labs ESOS 2010
2016
  • Vivimed’s FDF facility in Alathur completed successful USFDA inspection
  • Vivimed launch Jarocol Sapphire Blue
2020
  • Vivimed Launches its own brand of favipiravir.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
KRONE FINSTOCK PRIVATE LIMITEDbulkSell5810107.4110 Feb 2026
KRONE FINSTOCK PRIVATE LIMITEDbulkBuy60107.6810 Feb 2026
KAMAL JEET GUPTAbulkSell1300007.8220 Jan 2026
KAMAL JEET GUPTAbulkBuy4300008.1720 Jan 2026
NEO APEX VENTURE LLPbulkSell29897012.2506 Jan 2026
MERU INVESTMENTSbulkBuy45000012.2506 Jan 2026
NEO APEX VENTURE LLPbulkBuy104896312.2506 Jan 2026
A AND S TRADELINKbulkBuy7125736.4203 Apr 2023
LUHARUKA MEDIA & INFRA LTDbulkSell5516277.6621 Jun 2022
KRONE FINSTOCK PRIVATE LIMITEDbulkSell43100015.1529 Mar 2022

Read More

Vivimed Labs Ltd News

Vivimed Labs reschedules board meeting to May 30

Vivimed Labs postponed its board meeting from May 28 to May 30, 2026, to approve Q4FY26 and FY26 audited financial results.

26 May 2026

companies

Vivimed Labs Board Meeting Set for May 28, 2026

Vivimed Labs schedules Board meeting on May 28, 2026, to consider audited standalone and consolidated financial results for Q4 and full year ending March 31, 2026.

17 May 2026

companies

Vivimed Labs Insolvency Process Begins April 15

National Company Law Tribunal orders corporate insolvency resolution process for Vivimed Labs Limited with claims submission deadline May 1, 2026

26 Apr 2026

companies

Vivimed Labs CIRP Commences 15.04.2026

NCLT Bengaluru admitted Vivimed Labs Limited to CIRP on 15.04.2026. T Narayana Swamy appointed IRP. Creditors must submit claims by 01.05.2026.

23 Apr 2026

companies

Vivimed Labs Admitted to Insolvency Process by NCLT

NCLT Bengaluru admits Vivimed Labs to Corporate Insolvency Resolution Process following petition by Blue Cube Germany Assets over unpaid debt of ₹2,78,60,844.

17 Apr 2026

companies

Read More